Last updated on September 2017

Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014)


Brief description of study

This study aims to compare treatment with imipenem/relebactam/cilastatin (IMI/REL) as a fixed-dose combination (FDC) with piperacillin/tazobactam (PIP/TAZ) FDC in participants with hospital-acquired and ventilator-associated bacterial pneumonia. The primary hypothesis is that IMI/REL is non-inferior to PIP/TAZ in the incidence rate of all-cause mortality.

Clinical Study Identifier: NCT02493764

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Toll Free Number

Call for Information (Investigational Site 0514)
Birmingham, AL United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0512)
Sacramento, CA United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0504)
Miami, FL United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0518)
Chicago, IL United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0522)
Iowa City, IA United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0524)
Boston, MA United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0500)
Detroit, MI United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0506)
Las Vegas, NV United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0529)
Columbus, OH United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0525)
Philadelphia, PA United States
  Connect »

Alfredo Wilkinson

Merck Sharp & Dohme (Argentina) Inc.
Buenos Aires, Argentina
  Connect »

MSD Online

MSD Brasil
Sao Paulo, Brazil
  Connect »

Eran Gefen

Merck Sharp & Dohme Bulgaria EOOD
Sofia, Bulgaria
  Connect »

Francesca Carvajal

MDS Colombia SAS
Bogota, Colombia
  Connect »

Katrin Moeschlin

Merck Sharp & Dohme OU
Tallinn, Estonia
  Connect »

Dominique Blazy

MSD France
Paris, France
  Connect »

German Medical Information Center

MSD Sharp & Dohme GmbH
Haar, Germany
  Connect »

Soraya Cedraro

MSD CARD
Guatemala, Guatemala
  Connect »

Patrizia Nardini

MSD Italia S.r.l.
Rome, Italy
  Connect »

Japan Call Center

MSD K.K.
Chiyoda-Ku, Tokyo, Japan
  Connect »

Jongho Ahn

MSD Korea LTD
Seoul, Korea, Republic of
  Connect »

Katrin Moeschlin

Merck Sharp & Dohme Latvija SIA
Riga, Latvia
  Connect »

Juan Marques

MSD
Mexico City, Mexico
  Connect »

Cesar Recto

Merck Sharp & Dohme (I.A.) Corporation
Makati, Philippines
  Connect »

Ana Maria Nogueira

Merck Sharp & Dohme Lda.
Paco Darcos, Portugal
  Connect »

Simona Olaru

Merck Sharp & Dohme Romania SRL
Bucharest, Romania
  Connect »

Tatiana Serebriakova

Merck Sharp & Dohme IDEA, Inc.
Moscow, Russian Federation
  Connect »

Eran Gefen

MSD Ukraine LLC
Kiev, Ukraine
  Connect »